AI

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

AI

A step towards AI-based precision medicine

Jim Cornall - October 16, 2023

AI

Business and artificial intelligence – how can we prepare for the ‘fourth’ industrial revolution?

admin - October 2, 2023

AI

FlowGPT Hackathon to focus on AI creativity and ethics

Jim Cornall - September 7, 2023

AI

Ibex raises $55m to drive global adoption of AI for cancer diagnosis

Jim Cornall - September 7, 2023

AI

How AI can help dentists with early detection of tooth decay

Jim Cornall - August 8, 2023

AI

AI-enhanced productivity in the workspace

Jim Cornall - August 7, 2023

AI

BioMap unveils Life Science Leaderboard to compare AI models

Jim Cornall - August 7, 2023

1...5 67Page 7 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0